NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
 

(Note: All dollar amounts in this press release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from unaudited financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS® Accounting Standards”), except as otherwise noted. This press release contains certain non-GAAP and other financial measures, including book value per share and cash and marketable securities, that do not have a prescribed meaning under IFRS Accounting Standards and may not be comparable to similar financial measures presented by other issuers. See “Glossary of non-GAAP and other financial measures” at the end of this press release for further details.)
 

TORONTO, Feb. 19, 2026 (GLOBE NEWSWIRE) — Fairfax India Holdings Corporation (TSX:FIH) announces fiscal year 2025 net earnings of $410.5 million ($3.05 net earnings per diluted share), compared to a net loss of $41.2 million in fiscal year 2024 ($0.30 net loss per diluted share). The company’s book value per share increased 9.4% to $22.94 at December 31, 2025 from $20.96 at December 31, 2024 ($20.72 at September 30, 2025), primarily due to net gains on investments, partially offset by unrealized foreign currency translation losses as a result of the depreciation of the Indian rupee against the U.S. dollar during 2025.

Highlights for 2025 included the following:

  • Net change in unrealized gains on investments of $527.6 million principally from increases in the fair values of the company’s private company investments in BIAL ($399.1 million), Seven Islands ($24.0 million) and Global Aluminium ($13.8 million), and publicly listed investments in IIFL Finance ($146.0 million), CSB Bank ($114.4 million) and IIFL Capital ($35.0 million). The above was partially offset by decreases in the fair values of private company investments in Sanmar ($111.9 million) and Jaynix ($12.1 million), and publicly listed investments in Fairchem Organics ($40.6 million) and 5paisa ($11.5 million), as well as a reversal of prior period unrealized gains related to the sale of Saurashtra ($30.7 million).
  • Net realized gains on investments of $53.5 million principally related to the sale of the company’s 51.0% equity interest in Saurashtra. The sale was completed on November 14, 2025 for gross proceeds of $74.6 million (6.6 billion Indian rupees), resulting in a realized gain since inception of $52.0 million.
  • Interest and dividend income of $55.7 million primarily related to dividends received from Seven Islands ($34.4 million) and Jaynix ($8.1 million), and interest earned on Government of India bonds ($6.0 million).
  • Unrealized foreign currency translation losses recorded by the company relate to the translation of Indian rupee-denominated net assets into U.S. dollars, which is the company’s presentation currency. The company recorded unrealized foreign currency translation losses of $153.8 million during 2025 due to a 4.7% depreciation of the Indian rupee against the U.S. dollar.
  • The company purchased an additional 10.0% equity interest in BIAL in February 2025 for $255.0 million under deferred payment terms, and amended its revolving credit facility to facilitate the issuance of a letter of credit in favour of the seller to support the deferred purchase consideration. At December 31, 2025, the borrowing limit, including the temporary increase in connection with the issuance of a letter of credit, was $245.0 million (reducing to $220.0 million by October 1, 2026) and had a maturity date of November 13, 2028.
  • The company continued to buy back shares under its normal course issuer bid and during 2025 purchased for cancellation 620,658 subordinate voting shares at a net cost of $10.4 million ($16.81 per subordinate voting share).

Fairfax India is in strong financial health, with cash and marketable securities at December 31, 2025 of $50.7 million, and $168.5 million available under its revolving credit facility.

There were 134.7 million and 135.0 million weighted average common shares outstanding during the fourth quarters of 2025 and 2024, respectively. At December 31, 2025 there were 104,218,804 subordinate voting shares and 30,000,000 multiple voting shares outstanding.

Unaudited consolidated balance sheets, earnings (loss) and comprehensive income (loss) information follow and form part of this press release.

Fairfax India Holdings Corporation is an investment holding company whose objective is to achieve long term capital appreciation, while preserving capital, by investing in public and private equity securities and debt instruments in India and Indian businesses or other businesses with customers, suppliers or business primarily conducted in, or dependent on, India.

For further information, contact: John Varnell, Vice President, Corporate Affairs
  (416) 367-4755
 

Information on
CONSOLIDATED BALANCE SHEETS
as at December 31, 2025 and December 31, 2024
(unaudited – US$ thousands except per share amounts)

  December 31, 2025   December 31, 2024  
Assets            
Cash and cash equivalents   8,112     59,322  
Bonds   64,810     180,507  
Common stocks   3,972,524     3,381,206  
Total cash and investments   4,045,446     3,621,035  
             
Interest and dividends receivable   2,996     8,849  
Income taxes refundable   166     174  
Other assets   1,149     722  
Total assets   4,049,757     3,630,780  
             
Liabilities            
Accounts payable and accrued liabilities   1,043     1,300  
Accrued interest expense   8,787     8,611  
Income taxes payable   922     5,379  
Payable to related parties   10,960     10,099  
Payable for securities purchased   76,500      
Deferred income taxes   217,859     149,780  
Borrowings   498,870     498,349  
Total liabilities   814,941     673,518  
             
Equity            
Common shareholders’ equity   3,079,648     2,826,495  
Non-controlling interests   155,168     130,767  
Total equity   3,234,816     2,957,262  
    4,049,757     3,630,780  
             
Book value per share $ 22.94   $ 20.96  
 

Information on
CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
for the fourth quarters and years ended December 31, 2025 and 2024
(unaudited – US$ thousands except per share amounts)

  Fourth quarter
  Year ended December 31,
 
    2025